23 hrs ago | GuruFocus.com
Bruce Berkowitz Buys WellPoint Inc., BristolMyers Squibb Company,...
GuruFocus News Filed Under: JOE , SHLD , USG , LUK , DISH , MHK , MWA , WLP , BMY , SATS , MYL , ACF , Filed Under: JOE , SHLD , USG , LUK , DISH , MHK , MWA , WLP , BMY , SATS , MYL , ACF , Filed Under: JOE , ... via GuruFocus.com
Wednesday | Market Watch
Drug stocks follow market lower
Drug stocks followed the broader market lower early Friday as shares of Plavix makers Bristol-Myers Squibb and Sanofi-Aventis lost ground on news that Swiss drugmaker Schweizerhill Holdings AG was seeking to ... via Market Watch
Monday May 12 | Rocky Mountain News
High Court tosses itself off case
“This decision is particularly disturbing because the law was specifically designed to cure the problem of justices being reluctant to sell certain stocks because of capital gains consequences.”
Originally published 05:15 p.m., May 12, 2008 Updated 05:15 p.m., May 12, 2008 WASHINGTON - The Supreme Court couldn't take up an apartheid dispute involving some of the nation's largest companies because too ... via Rocky Mountain News
Saturday May 10 | News Channel 11
Italian Restaurant Is Coming To Downtown Bristol, Tenn.
“I don't know of any place in town where you can have a martini and a pizza. But this will not be a 'pizza place.' ”
BRISTOL, Tenn. Niccol di Bernardo dei Machiavelli would have been proud of the remodeled restaurant in downtown Bristol that will bear the name of the noted Italian Renaissance man. via News Channel 11
Friday May 9 | Earth Times
AIG loss, oil, drug firms rattle investors
“At some point oil gets too high for them to make money”
Stocks fell on Friday after American International Group , the world's largest insurer, reported a record $7.8 billion quarterly loss, rekindling concerns about financial services companies. via Earth Times
Thursday May 8 | Pravda
ConvaTec to belong to new owners
Private equity firms Avista Capital Partners and Nordic Capital have agreed to acquire biopharmaceutical business unit ConvaTec from Bristol-Myers Squibb Company for approximately $4.1bn, subject to adjustments ... via Pravda
Wednesday May 7 | Greensboro Business Journal
ConvaTec sells for $4.1 billion
Bristol-Myers Squibb has agreed to sell its ConvaTec business to Nordic Capital Fund and Avista Capital Partners for $4.1 billion. via Greensboro Business Journal
Monday May 5 | PE Hub
“In December 2007, we announced our evolution into the leading next-generation BioPharma company and that as part of the transformation we would undergo a thorough strategic review of our non-pharmaceutical assets”
Two buyout firms have agreed to a multi-billion dollar deal that has committed debt financing. via PE Hub
Saturday May 3 | Market Watch
Bristol-Myers to sell ConvaTec unit for $4.1 billion
Dave Johnson will remain the chief executive of ConvaTec, Bristol-Myers said. The New York-based drugmaker expects the deal to close in the third quarter. via Market Watch







